| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24c39e4dc286833abc38483ab3822aee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L12-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B1-043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-1613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B1-04 |
| filingDate |
2007-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_164d41a44a158452e3db9f6022c8ea3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_174329763ba7f8eb6b31505a9c529324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cd6e8d6c796d3d6ae70830636ac53e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14da0ad50cab3f91b78346ad3c70691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4763c3e5ea6c7dca14eb85015fa5750 |
| publicationDate |
2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2624960-T3 |
| titleOfInvention |
Method of manufacturing ophthalmic devices used in the treatment of eye allergies |
| abstract |
A method of making an ophthalmic device comprising a minimum effective amount of an antiallergic agent wherein the ophthalmic device is prepared from a formulation comprising etafilcon A, the antiallergic agent is ketotifen fumarate, and wherein the minimum effective amount of said antiallergic agent is between more than 9μg and less than 90 µg comprising the step of treating an ophthalmic device with a solution comprising said antiallergic agent, wherein the amount of said antiallergic agent in said solution exceeds the minimum effective amount in about 50% in a volume of solution that is around 1000 μl. |
| priorityDate |
2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |